Sagimet Biosciences Inc. - Series A Common Stock — Bilancio Trimestrale (NASDAQ:SGMT) | MetaTrader

Apri il grafico completo Full chart

Notizie

Wall Street Analysts Believe Sagimet Biosciences Inc. (SGMT) Could Rally 298.5%: Here's is How to Trade

Citizens taglia il target su Sagimet Biosciences per valutazione

Sagimet Biosciences Inc. (SGMT) is a Great Momentum Stock: Should You Buy?

Does Sagimet Biosciences Inc. (SGMT) Have the Potential to Rally 241.77% as Wall Street Analysts Expect?

3 Penny Stocks to Watch Now, 4/28/26 - TipRanks.com

Oppenheimer alza il target su Sagimet puntando sull’acne

Sagimet fissa a 175 milioni di dollari l’offerta azionaria per finanziare studi sul farmaco per l’acne

Le azioni di Sagimet Biosciences salgono del 30% sui piani per trial sull’acne

Sagimet Biosciences nomina Andreas Grauer direttore medico

Sagimet Biosciences Inc. (SGMT) Presents at Fueling MASH: Metabolic Drivers and Inflammatory Crosstalk Keystone Symposium - Slideshow (NASDAQ:SGMT) 2026-04-20

Citizens conferma il rating su Sagimet Biosciences per progressi MASH

Citizens reiterates Sagimet Biosciences stock rating on MASH progress